Thousands of people who used a weight-loss supplement will be receiving a portion of more than $400,000, according to the ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever. Earlier this week, Novo Nordisk tore up a partnership ...

It is illegal to advertise prescription-only weight loss drugs and Ms Collins' was one of nine adverts banned in a crackdown ...

The weight loss drug Wegovy may do more than help people lose weight New trial results show the weight-loss medication Wegovy can also cut heart attack and stroke risks, according to the drug's maker.

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

And Lilly’s other weight loss drug, tirzepatide, was shown to reduce body weight, on average, by 22.5% on average, or about 52 pounds, after 72 weeks.

For example, Medicare does not cover weight loss medication, though it covers counseling and weight loss surgery for those of a certain BMI. However, if approved, the drug is expected to do well.

In 2023, the FDA will likely approve Eli Lilly's diabetes drug tirzepatide for weight loss — but there's little indication insurers will widely cover the medication. IE 11 is not supported.

In trials of Wegovy, up to 40% of weight loss was from a decrease in lean or fat-free mass, rather than excess fat. In addition, quitting the drugs can mean adding back the pounds.

But the drug's side effect of rapid weight loss quickly stole headlines and made Ozempic a very hot commodity. So hot, it caused some problems for the people it was originally intended to help.

The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity drugs.. The drug, which will ...